F. Donatelli et al., SURGICAL-TREATMENT FOR LIFE-THREATENING ACUTE MYOCARDIAL-INFARCTION -A PROSPECTIVE PROTOCOL, European journal of cardio-thoracic surgery, 11(2), 1997, pp. 228-233
Objective: In this paper we describe the preliminary results of a pros
pective operative protocol designed in order to define the role of eme
rgent myocardial revascularization in extensive acute miocardial infar
ction and in post-infarction cardiogenic shock. Methods: Entry criteri
a are: age <75 years; anterior acute myocardial infarction with ST seg
ment elevation >4 leads, infero-postero-lateral or inferior and right
ventricular, within 6 h from onset of chest pain; post-infarction card
iogenic shock within 3 h from onset of shock. From November 1994 to Ju
ly 1995, after emergency coronary arteriography, 23 patients were trea
ted by coronary artery bypass grafting. Fifteen were operated for exte
nsive acute myocardial infarction (group A, mean age 54.1 +/- 9.4 year
s) and eight for post-infarction cardiogenic shock (group B mean age 6
5.0 +/- 8.7 years). Mean time from onset was 4.4 +/- 1.3 h in group A
and 2.2 +/- 0.8 h in group B. Mean left ventricular ejection fraction
was 39.3 +/- 12.7% in group A and 22.6 +/- 3.5% in group B. Six out of
eight group B patients needed intraaortic balloon counterpulsation pr
eoperatively, and 2/8 cardiopulmonary resuscitation. Results: Myocardi
al revascularization consisted in 3.4 +/- 1.1 grafts in group A (vein
grafts, except for 8 patients who also received a left internal thorac
ic artery graft) and 3.3 +/- 1.1 vein grafts in group B. All patients
in group B and 3/15 (20%) in group A underwent intraaortic balloon cou
nterpulsation. In-hospital death occurred in 1/15 (6.7%) patients of g
roup A and in 4/8 (50%) patients of group B. At a mean follow-up of 4.
1 +/- 3.3 months for group A and of 3.9 +/- 2.2 months for group B lef
t ventricular ejection fraction was 43.4 +/- 9.0% in group A and 35.7
+/- 13.1% in group B. Conclusions: Experience of 9 months with this pr
ospective protocol showed its effectiveness in the management of criti
cally ill patients with acute coronary occlusion leading to low mortal
ity rate in acute myocardial infarction and improved survival rate in
post-infarction cardiogenic shock. (C) 1997 Elsevier Science B.V.